Biotechnology markets include the tools, consumables, services and intellectual property necessary for life sciences and applied medical research. The products of such research include biopharmaceuticals, vaccines, and other biologics. Emerging markets like that of mass spectrometry used in clinical testing applications highlight technological advances that urge more companies to make deals in the field of biotechnology. As the industry grows, companies will develop and integrate automated platforms and diagnostic kits that greatly increase convenience and reliability. This efficiency-mindedness had permeated the past decade in the biotechnology field, as the pace and breadth of translational or biomedical research has created multi-billion dollar markets for research tools and services as well as for the discovered and subsequently marketed biologics. In the future, companies hope to see convenient clinical diagnostic applications eventually coming into multiple areas of the clinical lab.
Next Generation Sequencing
Proteomics
Biopharmaceuticals
Instrumentation & Equipment
Emerging Technologies
- Display 15 Products per page
Published: January 1, 2022 | Price:
How Do You Plan to Keep Up With Developments in The Business of Cell and Gene Therapy in 2022? Consider Cell and Gene Therapy Business Outlook Each week brings news in Cell and Gene Therapy, from advances in clinical trials to product launches, from tools development to mergers and acquisitions. It can be a daunting task to keep up. Yet these developments are too fast-moving and significant for healthcare companies of any type to ignore. Now from Science and Medicine...Published: May 4, 2018 | Price: $4,500.00 – $9,000.00
Single Use Upstream Bioprocessing Markets (Bioreactors, Media Bags, Bioprocess Containers, Tubing and Connectors, Mixing Systems, Sensors and Probes) Single Use Upstream Bioprocessing Markets (Bioreactors, Media Bags, Bioprocess Containers, Tubing and Connectors, Mixing Systems, Sensors and Probes) analyzes the current and potential world market for single use systems for upstream bioprocessing. This report generally reviews the nature and direction of research, as well as future markets. Market forecasts cover various segments from 2016-2021, including global revenues for single use upstream processing;...Published: July 1, 2013 | Price: $1,500.00 – $3,000.00
Next Generation Sequencing Trends (Clinical Applications, Systems Used, Accreditation Status, Regulated Patient Sample Handling and Other Trends) Next-generation sequencing is discussed frequently as a key to clinical diagnostics in the future. This report looks at the status of NGS today, and seeks to provide insights on the “on-the-ground” status of clinical sequencing. In the course of doing this, the report seeks to answer the following questions: What is the status of clinical applications for Next Gen in laboratories currently? What...Published: July 1, 2003 | Price: $2,625.00 – $5,250.00
In today's world of Orthopedic Biomaterials, one thing that is expanding rapidly is the amount of new products in the research pipeline: stem cells, bone growth factors, gene therapy, synthetic bone fillers, bioactive implant coatings and biopolymers among others. The overall market is expected to enjoy healthy growth over the next 5 years, but the number one expansion story is in the bone growth factors and proteins segment, so called orthobiologics. These products could grow from just a few percent...Published: March 2, 2018 | Price: $3,995.00 – $7,990.00
PCR Markets for Life Sciences Applications (Market by Type - qPCR, dPCR - Application - Pharmaceutical, General Research, and by Country and Region) As part of its coverage of this market, Kalorama Information's report provides: The Market for Life Sciences PCR, 2017 to 2022 Application Market Segmentation of Pharmaceutical and General Medical Research Market Segmentation of qPCR and dPCR markets, 2017-2022 United States Life Sciences PCR Market, 2017-2022 European Life Sciences PCR Market, 2017-2022 Japanese Market for Life Sciences PCR,...Published: October 22, 2014 | Price: $995.00 – $1,990.00
qPCR and dPCR Markets (Instruments, Reagents, Software/Services, Clinical and Research Markets) Kalorama Information's qPCR and dPCR Markets is a complete look at two imporant technologies in research and clinical practice. Th covers the qPCR and dPCR portion of the global IVD market. The report covers software, instruments and consumables, with data provided for 2014 through 2018.Published: October 7, 2016 | Price: $3,360.00 – $6,720.00
This Kalorama report, Gene Editing Markets (CRISPR-based, Zinc Finger Nuclease [ZFN], TALEN, Other), provides global Revenues and Forecast for the gene editing market by type of product including consumables, instruments, services, cell-lines, animal models. Gene editing, or changing genes at specific parts of the genome of a human, plant or animal is a topic of increasing interest. This report breaks out the gene editing market by region and also by application area including: drug discovery & development, life sciences research,...Published: April 7, 2020 | Price: $750.00 – $1,000.00
For years, Kalorama Information has covered the fields of molecular diagnostics, immunoassays, vaccines and telehealth. These all find themselves both sought-after and challenged during the current COVID-19 crisis. This report provides trending developments, company announcements and analysis from the Kalorama analysis team on the fast-breaking events in the COVID-19 epidemic. Particular sections address the most important market changes: Molecular Diagnostics: It's important to note that the entire molecular testing concept originated in the midst of a crisis, at that time...Published: June 19, 2015 | Price: $4,200.00 – $8,400.00
The Market for Circulating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs) Circulating tumor cells (CTCs) have tremendous utility in cancer research, aiding researchers in deciphering the complex processes leading to cancer metastasis and in developing more effective cancer therapeutics. Besides the research applications, the detection and analysis of CTCs has enormous potential in the diagnosis and management of cancer, as current tools, such as tumor tissue biopsy or imaging technologies, have numerous limitations. Although their biology and characteristics are...Published: November 12, 2018 | Price: $4,500.00 – $9,000.00
World Market for Biopharmaceutical Drug Delivery Device Technology The total market for biopharmaceutical drug delivery is very complex and shifting due to technological advancements. Though the market to date has been dominated by injectable administration, injections are not the first choice among patients and compliance is an ongoing issue. Further, as the majority of new entities in development are biologics requiring advanced drug delivery, manufacturers of devices have been busy developing new innovations that will meet the current needs of...Published: August 15, 2013 | Price: $3,995.00 – $7,990.00
The Market for Circulating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs) Circulating tumor cells (CTCs) are believed to detach from primary or secondary tumors and enter the bloodstream, traveling to distant organs and forming new tumors. These cells that leave the primary tumor are able to colonize distant organs in the body and initiate the process of metastasis; however, their biology is still not entirely elucidated. Circulating tumor cells have tremendous utility in cancer research, aiding scientists in deciphering...Published: January 6, 2022 | Price: $5,000.00 – $10,000.00
This report, The World Liquid Biopsy Market, 2021, from Kalorama Information, contains up-to-date information and useful data points for business planning: Research vs. Clinical Liquid Biopsy The Market for Liquid Biopsy by Region The Market for Liquid Biopsy Market by Type of Analyte The Market for CTC-based Liquid Biopsy The Market for ctDNA-based Liquid Biopsy The Market for EV and Exosome-based Liquid Biopsy The Market for Multi-Analyte-based Liquid Biopsy The Market for Other Liquid Biopsy Liquid Biopsy Market by Type...Published: September 1, 2004 | Price: $895.00 – $1,790.00
Nanotechnology is no longer a bench-top curiosity. It is becoming a real commercial force for a variety of applications. This market briefing discusses the state of play in the race to commercialize products and forecasts likely market scenarios. The briefing forecasts the market in generally promising areas such as cancer therapeutics, specialized drug delivery, diagnostics, and topical therapies, reviewing what companies are doing in those markets.Published: February 1, 2010 | Price: $1,995.00 – $4,000.00
Because SNPs are the most common type of genetic variation between human beings, these specific single base pair mutations can be ideal for the task of hunting for correlations between genotype and behavior or quality exhibited by a living organism. For this reason, SNP analysis represents one of many possible pathways to personalzied medicine. The use of SNP analysis has spread into numerous areas in recent years. But diagnostics and pharmacogenomics are the most promising applications, and Kalorama has followed...Published: December 29, 2023 | Price: $5,000.00 – $10,000.00
Liquid biopsies have emerged as a minimally invasive diagnostic tool, analyzing tumor-derived materials circulating in biological fluids to offer valuable information for cancer diagnosis, treatment, and monitoring. While tissue biopsies and imaging techniques remain standard in solid tumor diagnosis, liquid biopsies present an alternative or complementary approach, addressing some of the limitations and risks associated with traditional methods. Key applications of liquid biopsy testing in clinical oncology include: Early Detection and Diagnosis/Screening: Identifying cancer at an early stage. Alternative Testing...